Ontrak, Inc. (OTRKP)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.57 Million USD | -72.24% |
| 2022 | 20.08 Million USD | -58.28% |
| 2021 | 48.12 Million USD | -42.67% |
| 2020 | 83.95 Million USD | 75.76% |
| 2019 | 47.76 Million USD | 212.43% |
| 2018 | 15.28 Million USD | 167.93% |
| 2017 | 5.7 Million USD | -79.93% |
| 2016 | 28.43 Million USD | 145.02% |
| 2015 | 11.6 Million USD | -73.37% |
| 2014 | 43.57 Million USD | 110.86% |
| 2013 | 20.66 Million USD | 10.56% |
| 2012 | 18.69 Million USD | 131.45% |
| 2011 | 8.07 Million USD | -55.43% |
| 2010 | 18.12 Million USD | 10.06% |
| 2009 | 16.46 Million USD | -46.47% |
| 2008 | 30.75 Million USD | 12.33% |
| 2007 | 27.38 Million USD | 169.08% |
| 2006 | 10.17 Million USD | 115.46% |
| 2005 | 4.72 Million USD | 121.95% |
| 2004 | 2.12 Million USD | 1.72% |
| 2003 | 2.09 Million USD | 271.68% |
| 2002 | 562.85 Thousand USD | 5590.53% |
| 2001 | 9891.00 USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 9.86 Million USD | 80.09% |
| 2024 Q1 | 5.47 Million USD | -1.78% |
| 2023 Q3 | 25.39 Million USD | 16.21% |
| 2023 Q2 | 21.85 Million USD | 19.91% |
| 2023 Q1 | 18.22 Million USD | -9.23% |
| 2023 FY | 5.57 Million USD | -72.24% |
| 2023 Q4 | 5.57 Million USD | -78.05% |
| 2022 Q4 | 20.08 Million USD | 15.05% |
| 2022 Q3 | 17.45 Million USD | 14.74% |
| 2022 Q2 | 15.21 Million USD | -44.89% |
| 2022 Q1 | 27.6 Million USD | -42.65% |
| 2022 FY | 20.08 Million USD | -58.28% |
| 2021 Q3 | 63.52 Million USD | -14.55% |
| 2021 Q2 | 74.33 Million USD | -15.77% |
| 2021 Q1 | 88.26 Million USD | 5.14% |
| 2021 FY | 48.12 Million USD | -42.67% |
| 2021 Q4 | 48.12 Million USD | -24.24% |
| 2020 Q4 | 83.95 Million USD | 23.18% |
| 2020 FY | 83.95 Million USD | 75.76% |
| 2020 Q1 | 50.34 Million USD | 5.39% |
| 2020 Q2 | 55.09 Million USD | 9.44% |
| 2020 Q3 | 68.15 Million USD | 23.71% |
| 2019 Q1 | 17.89 Million USD | 17.04% |
| 2019 Q4 | 47.76 Million USD | 13.26% |
| 2019 Q3 | 42.17 Million USD | 49.46% |
| 2019 FY | 47.76 Million USD | 212.43% |
| 2019 Q2 | 28.21 Million USD | 57.69% |
| 2018 FY | 15.28 Million USD | 167.93% |
| 2018 Q1 | 4.69 Million USD | -17.65% |
| 2018 Q2 | 12.52 Million USD | 166.55% |
| 2018 Q3 | 16.18 Million USD | 29.25% |
| 2018 Q4 | 15.28 Million USD | -5.57% |
| 2017 Q2 | 4.85 Million USD | -89.78% |
| 2017 FY | 5.7 Million USD | -79.93% |
| 2017 Q1 | 47.54 Million USD | 67.21% |
| 2017 Q4 | 5.7 Million USD | 2.59% |
| 2017 Q3 | 5.56 Million USD | 14.47% |
| 2016 Q3 | 28.43 Million USD | 46.15% |
| 2016 Q2 | 19.45 Million USD | 30.51% |
| 2016 FY | 28.43 Million USD | 145.02% |
| 2016 Q1 | 14.9 Million USD | 28.47% |
| 2016 Q4 | 28.43 Million USD | -0.01% |
| 2015 FY | 11.6 Million USD | -73.37% |
| 2015 Q4 | 11.6 Million USD | -17.24% |
| 2015 Q3 | 14.02 Million USD | 95.33% |
| 2015 Q2 | 7.17 Million USD | -82.81% |
| 2015 Q1 | 41.75 Million USD | -4.17% |
| 2014 Q3 | 43.82 Million USD | -3.09% |
| 2014 Q4 | 43.57 Million USD | -0.57% |
| 2014 FY | 43.57 Million USD | 110.86% |
| 2014 Q1 | 17.98 Million USD | -12.98% |
| 2014 Q2 | 45.22 Million USD | 151.46% |
| 2013 Q3 | 18.68 Million USD | -9.71% |
| 2013 Q2 | 20.68 Million USD | 45.09% |
| 2013 Q1 | 14.25 Million USD | -23.72% |
| 2013 FY | 20.66 Million USD | 10.56% |
| 2013 Q4 | 20.66 Million USD | 10.63% |
| 2012 Q1 | 9.57 Million USD | 18.54% |
| 2012 FY | 18.69 Million USD | 131.45% |
| 2012 Q2 | 11.95 Million USD | 24.88% |
| 2012 Q3 | 11.88 Million USD | -0.59% |
| 2012 Q4 | 18.69 Million USD | 57.29% |
| 2011 Q1 | 10.11 Million USD | -44.2% |
| 2011 FY | 8.07 Million USD | -55.43% |
| 2011 Q2 | 4.13 Million USD | -59.13% |
| 2011 Q3 | 5 Million USD | 21.0% |
| 2011 Q4 | 8.07 Million USD | 61.49% |
| 2010 Q3 | 4.11 Million USD | -49.02% |
| 2010 Q2 | 8.07 Million USD | -46.21% |
| 2010 Q4 | 18.12 Million USD | 340.26% |
| 2010 FY | 18.12 Million USD | 10.06% |
| 2010 Q1 | 15 Million USD | -8.84% |
| 2009 Q2 | 16.2 Million USD | 1.01% |
| 2009 Q1 | 16.04 Million USD | -47.85% |
| 2009 Q4 | 16.46 Million USD | -22.52% |
| 2009 Q3 | 21.24 Million USD | 31.14% |
| 2009 FY | 16.46 Million USD | -46.47% |
| 2008 Q3 | 30.87 Million USD | 7.71% |
| 2008 Q4 | 30.75 Million USD | -0.37% |
| 2008 Q1 | 24.29 Million USD | -11.28% |
| 2008 FY | 30.75 Million USD | 12.33% |
| 2008 Q2 | 28.66 Million USD | 17.98% |
| 2007 Q1 | 28.46 Million USD | 179.73% |
| 2007 Q3 | 29.26 Million USD | 3.64% |
| 2007 Q2 | 28.24 Million USD | -0.79% |
| 2007 FY | 27.38 Million USD | 169.08% |
| 2007 Q4 | 27.38 Million USD | -6.45% |
| 2006 Q3 | 7.42 Million USD | 19.58% |
| 2006 Q1 | 4.83 Million USD | 2.37% |
| 2006 Q4 | 10.17 Million USD | 37.03% |
| 2006 Q2 | 6.21 Million USD | 28.44% |
| 2006 FY | 10.17 Million USD | 115.46% |
| 2005 Q3 | 3.7 Million USD | 30.23% |
| 2005 Q4 | 4.72 Million USD | 27.48% |
| 2005 Q1 | 2 Million USD | -6.02% |
| 2005 FY | 4.72 Million USD | 121.95% |
| 2005 Q2 | 2.84 Million USD | 42.25% |
| 2004 Q1 | 2.06 Million USD | -1.29% |
| 2004 FY | 2.12 Million USD | 1.72% |
| 2004 Q4 | 2.12 Million USD | -13.71% |
| 2004 Q3 | 2.46 Million USD | 43.04% |
| 2004 Q2 | 1.72 Million USD | -16.51% |
| 2003 Q3 | 1.36 Million USD | 0.0% |
| 2003 Q4 | 2.09 Million USD | 53.04% |
| 2003 FY | 2.09 Million USD | 271.68% |
| 2003 Q1 | 435.41 Thousand USD | -22.64% |
| 2002 Q4 | 562.85 Thousand USD | 0.0% |
| 2002 FY | 562.85 Thousand USD | 5590.53% |
| 2002 Q1 | 28.34 Thousand USD | 0.0% |
| 2001 FY | 9891.00 USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accolade, Inc. | 342.68 Million USD | 98.373% |
| CareCloud, Inc. | 37.79 Million USD | 85.25% |
| CareCloud, Inc. | 37.79 Million USD | 85.25% |
| Health Catalyst, Inc. | 334.89 Million USD | 98.335% |
| HealthEquity, Inc. | 1.2 Billion USD | 99.536% |
| iCoreConnect Inc. | 11.24 Million USD | 50.411% |
| Nutex Health, Inc. | 319.13 Million USD | 98.253% |
| Omnicell, Inc. | 1.03 Billion USD | 99.463% |
| Progyny, Inc. | 203.19 Million USD | 97.256% |
| Renalytix Plc | 15.82 Million USD | 64.773% |
| Simulations Plus, Inc. | 14.2 Million USD | 60.762% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | 75.683% |
| Definitive Healthcare Corp. | 626.72 Million USD | 99.11% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.892% |
| OneMedNet Corporation | 13.32 Million USD | 58.154% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 99.558% |
| Minerva Surgical, Inc. | 51.71 Million USD | 89.221% |
| SOPHiA GENETICS SA | 54.71 Million USD | 89.811% |
| Schrödinger, Inc. | 254.39 Million USD | 97.809% |
| HealthStream, Inc. | 159.19 Million USD | 96.498% |
| Augmedix, Inc. | 43.39 Million USD | 87.152% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.978% |
| Sharecare, Inc. | 125.56 Million USD | 95.56% |
| Aclarion, Inc. | 3.18 Million USD | -74.887% |
| CareMax, Inc. | 561.85 Million USD | 99.008% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -2924.139% |
| Forian Inc. | 33.19 Million USD | 83.206% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -2924.139% |
| HeartBeam, Inc. | 1.19 Million USD | -366.918% |
| GeneDx Holdings Corp. | 245.65 Million USD | 97.731% |
| SCWorx Corp. | 2.42 Million USD | -129.919% |
| 10x Genomics, Inc. | 224.1 Million USD | 97.512% |
| Zhongchao Inc. | 3.37 Million USD | -65.015% |
| MSP Recovery, Inc. | 1.74 Billion USD | 99.68% |
| R1 RCM Inc. | 2.2 Billion USD | 99.748% |
| Spok Holdings, Inc. | 63.91 Million USD | 91.277% |
| Privia Health Group, Inc. | 392.51 Million USD | 98.58% |
| EUDA Health Holdings Limited | 8.79 Million USD | 36.593% |
| TruBridge, Inc. | 247.8 Million USD | 97.75% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.892% |
| Sharecare, Inc. | 125.56 Million USD | 95.56% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 99.326% |
| Premier, Inc. | 1.46 Billion USD | 99.62% |
| Certara, Inc. | 516.29 Million USD | 98.92% |
| GeneDx Holdings Corp. | 245.65 Million USD | 97.731% |
| Ontrak, Inc. | 5.57 Million USD | 0.0% |
| SHL Telemedicine Ltd. | 36.58 Million USD | 84.763% |
| CareCloud, Inc. | 37.79 Million USD | 85.25% |
| EUDA Health Holdings Limited | 8.79 Million USD | 36.593% |
| HeartBeam, Inc. | 1.19 Million USD | -366.918% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -1919.642% |
| CareMax, Inc. | 561.85 Million USD | 99.008% |
| Healthcare Triangle, Inc. | 9.51 Million USD | 41.384% |
| National Research Corporation | 73.48 Million USD | 92.413% |
| Aclarion, Inc. | 3.18 Million USD | -74.887% |
| OptimizeRx Corporation | 56.82 Million USD | 90.188% |